Evidence map›Paper›PMID 28421601›Full record

ArticleThe British journal of dermatology2017

Evaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool-Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists.

J Tiao, R Feng, E M Berger, J F Brandsema, C C Coughlin, N Khan, E A Kichula, M A Lerman, S Lvovich, P J McMahon and 10 more

Open access · greenAbstract readComparative StudyEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Outcome Scores in Pediatric Rheumatology.Current rheumatology reports · 2021
    Review
  12. Review
  13. Review
  14. Classification of myositis.Nature reviews. Rheumatology · 2018
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 1 country.

J TiaoDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, U.S.A.ORCID http://orcid.org/0000-0001-8793-9456
R FengCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, U.S.A.
E M BergerHackensack University Medical Center, Hackensack, NJ, U.S.A.
J F BrandsemaDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, U.S.A.
C C CoughlinDivision of Dermatology, Washington University School of Medicine, St Louis, MO, U.S.A.
N KhanDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, U.S.A.
E A KichulaDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, U.S.A.
M A LermanDivision of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, U.S.A.
S LvovichSt Christopher's Hospital for Children, Philadelphia, PA, U.S.A.
P J McMahonDivision of Dermatology, Children's Hospital of Philadelphia, Philadelphia, PA, U.S.A.
L G RiderEnvironmental Autoimmunity Group. Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, U.S.A.
A I RubinDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, U.S.A.
L V ScalziPenn State Children's Hospital, Hershey, PA, U.S.A.
D M SmithDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, U.S.A.
A J TaxterBrenner Children's Hospital, Wake Forest Baptist Medical Center, Winston-Salem, NC, U.S.A.
J R TreatDivision of Dermatology, Children's Hospital of Philadelphia, Philadelphia, PA, U.S.A.
R P WilliamsMinneapolis Clinic of Neurology, Maple Grove, MN, U.S.A.
S W YumDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, U.S.A.
J OkawaDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, U.S.A.
V P WerthDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, U.S.A.
Children's Hospital of Philadelphia · USPhiladelphia VA Medical Center · USAtrium Health Wake Forest Baptist · USCenter for Clinical Research (United States) · USHackensack University Medical Center · USNational Institute of Environmental Health Sciences · USPenn State Milton S. Hershey Medical Center · USSt. Christopher's Hospital for Children · USUniversity of Minnesota Health Maple Grove Clinics · USUniversity of Pennsylvania · USWashington University in St. Louis · US

Funding

Assessment, Therapy and Prevention Of Autoimmune DiseaseZIAES101081 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RIDER, LISA · 2009 to 2025
$17.6M
Treatment of Dermatomyositis with Ajulemic Acid, a Non-Psychoactive CannabinoidR21AR066286 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI WERTH, VICTORIA P · 2014 to 2016
$387k
Intramural NIH HHS Z99 ES999999Intramural NIH HHS ZIA ES101081NIAMS NIH HHS R21 AR066286
6 · The paper itself

Abstract

backgroundThe Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool-Binary Method (CAT-BM) have been shown to be reliable and valid outcome measures to assess cutaneous disease in adult dermatomyositis (DM) and juvenile DM (JDM), respectively.

objectivesThis study compared the CDASI and CAT-BM for use by paediatric dermatologists, paediatric rheumatologists and paediatric neurologists in patients with JDM.

methodsFive paediatric dermatologists, five paediatric rheumatologists and five paediatric neurologists each evaluated 14 patients with JDM using the CDASI, CAT-BM, and skin Physician Global Assessment (PGA) scales. Inter-rater reliability, intra-rater reliability, construct validity and completion time were compared.

resultsInter-rater reliability for CDASI activity and damage scores was good to moderate for paediatric dermatologists and rheumatologists, but poor for paediatric neurologists. The inter-rater reliability for CAT-BM activity scores was moderate for paediatric dermatologists and rheumatologists, but poor for paediatric neurologists and poor across all specialties for damage scores. Intra-rater reliability for the CDASI and CAT-BM activity and damage scores was moderate to excellent for paediatric dermatologists, rheumatologists and neurologists. Strong associations were found between skin PGA activity and damage scores and CDASI or CAT-BM activity and damage scores, respectively (P < 0·002). The CDASI had a mean completion time of 5·4 min compared with that for the CAT-BM of 3·1 min.

conclusionsOur data confirm the reliability of the CDASI activity and damage scores and the CAT-BM activity scores when used by paediatric dermatologists and rheumatologists in assessing JDM. Significant variation existed in the paediatric neurologists' scores.

Indexed as

Severity of Illness IndexChildDermatologistsDermatomyositisFemaleHumansMaleNeurologistsObserver VariationPhysical ExaminationRheumatologistsSensitivity and Specificity

Identifiers

PMID28421601
PMCPMC5648622
OpenAlexW2606274050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.